UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 8-K


                                 CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of the
                       Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): June 29, 2017


                               CEL-SCI CORPORATION
                      ------------------------------------
             (Exact name of Registrant as specified in its charter)



      Colorado                      001-11889                 84-0916344
----------------------------   ---------------------   ------------------------
(State or other jurisdiction   (Commission File No.)      (IRS Employer
of incorporation)                                       Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)



      Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)



<PAGE>


Item 3.03.  Material Modification to Rights of Security Holders.

     On June 29, 2017 the Company  extended the expiration date of its Series DD
warrants  by one month  from July 10,  2017 to August  10,  2017.  The Series DD
warrants  were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split  approved by the Company's  shareholders  and adopted by
the Company's  directors,  the holders of the Series DD warrants are entitled to
purchase  1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share



                                       2

<PAGE>


                                  SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  July 5, 2017                     CEL-SCI CORPORATION



                                        By: /s/ Patricia Prichep
                                            -------------------------------
                                            Patricia Prichep
                                            Senior Vice President of Operations
[{"type": "8-K", "sequence": "1", "filename": "form8kitem303ddwarr7-17.txt", "description": "8-K RE SERIES DD WARRANTS", "secsgml_size_bytes": 2597}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "17952454"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 8-K

                                 CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of the
                       Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): June 29, 2017

                               CEL-SCI CORPORATION
                      ------------------------------------
             (Exact name of Registrant as specified in its charter)

      Colorado                      001-11889                 84-0916344
----------------------------   ---------------------   ------------------------
(State or other jurisdiction   (Commission File No.)      (IRS Employer
of incorporation)                                       Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)

      Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
                          ---------------------------
          (Former name or former address if changed since last report)
Item 3.03.  Material Modification to Rights of Security Holders.

     On June 29, 2017 the Company  extended the expiration date of its Series DD
warrants  by one month  from July 10,  2017 to August  10,  2017.  The Series DD
warrants  were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split  approved by the Company's  shareholders  and adopted by
the Company's  directors,  the holders of the Series DD warrants are entitled to
purchase  1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share

                                       2
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  July 5, 2017                     CEL-SCI CORPORATION

                                        By: /s/ Patricia Prichep
                                            -------------------------------
                                            Patricia Prichep
                                            Senior Vice President of Operations